Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
Official title: Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery
Run by Assistance Publique - Hôpitaux de Paris · NCT07439276 · Data updated 2026-11-12
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 16 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | April 8, 2026 |
| Main results expected | April 2029 |
| Study ends | April 2029 |
| Registry record updated | April 16, 2026 |
| Trial ID | NCT07439276 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Eligible patients are French-speaking children and adolescents aged 8–16 with a diagnosis of autism spectrum disorder, ADHD, or multiple complex/atypical neurodevelopmental presentations, who have an IQ above 70 and stable psychotropic medication for at least six weeks.
✕Probably not a fit
Children younger than 8 or older than 16, non–French speakers, those with IQ ≤ 70, active neurological disorders (e.g., active epilepsy), or recent changes in psychotropic medication are unlikely to be eligible or to benefit from these specific assessment procedures.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical project uses a multidimensional battery to measure four core domains of social cognition—emotion processing, social perception, theory of mind, and attributional style—in children and adolescents aged 8 to 16. Participants diagnosed with autism spectrum disorder, attention-deficit/hyperactivity disorder, or atypical neurodevelopment will complete standardized tests and questionnaires administered in French, with cognitive functioning confirmed by an IQ > 70. The protocol excludes children with active neurological disorders or recent medication changes and collects detailed profiles to map patterns of socio-cognitive strengths and deficits across diagnostic groups. Investigators aim to use these profiles to refine clinical characterization and identify disorder-specific therapeutic targets and assessment gaps.
Why it matters
Potential benefit: If successful, the battery could help clinicians detect specific social-cognitive difficulties earlier and guide more tailored interventions for children with neurodevelopmental disorders.
How similar studies have gone: Components of this approach (e.g., theory of mind or emotion-processing tests) have shown utility in prior pediatric research, but a single validated multidimensional battery for broad clinical use in 8–16-year-olds remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children and adolescents aged 8 to 16 years * Proficiency in French (native language) * Information and consent obtained from those holding parental authority, and agreement from the child or adolescent * No recently modified (\<6 weeks) psychotropic medication from the following categories: antidepressants, anxiolytics, antipsychotics, psychostimulants, mood stabilizers. * IQ above 70 (WISC-V) * Criteria for Neurodevelopmental Disorders: Diagnosis of Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder (according to DSM-5) * Multiple complex developmental disorder : Symptoms characteristic of a neurodevelopmental disorder without meeting all the criteria for a specific disorder and presence of multiple complex developmental disorder criteria with at least 5 elements from the specified categories. Exclusion Criteria: \- Having an active neurological disorder (e.g., active epilepsy)
Where it's running
-
Hôpital Necker-Enfants Malades
Paris, France Recruiting
Study contacts
- Principal investigator: Dorothée Leunen — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Dorothée Leunen
- Email: dorothee.leunen@aphp.fr
- Phone: 0171196346
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focused Acceptance and Commitment Therapy for Parents of Children with Special Healthcare Needs
This study is trying out a video-based therapy program to see if it can help parents of children with special healthcare needs feel less stressed and improve their parenting during tough times.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Playful physiotherapy to support children with ADHD or autism
This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.
-
High- and low-frequency paired associative deep TMS for ADHD
This trial tests whether high- or low-frequency paired deep transcranial magnetic stimulation (dTMS) to the prefrontal cortex can help adults with ADHD by balancing cortical arousal between the brain hemispheres.
-
Assessing motor and voice development in infants
This study is trying to see if watching videos of infants can help spot early signs of physical disabilities, especially for those at risk of Cerebral Palsy, by looking at their movement and voice development.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.